United Asset Strategies, Inc. Bristol Myers Squibb CO Transaction History

United Asset Strategies, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 08, 2020	SELL	$46.4 - $67.43 $176,459 - $256,436	-3,803 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$49.21 - $64.19 $187,145 - $244,114	3,803 New	3,803 $244,000
Q1 2019 May 02, 2019	SELL	$45.12 - $53.8 $190,947 - $227,681	-4,232 Closed	0 $0
Q4 2018 Feb 11, 2019	SELL	$48.76 - $63.23 $13,165 - $17,072	-270 Reduced 6.0%	4,232 $220,000
Q2 2018 Aug 07, 2018	SELL	$50.53 - $62.98 $5,053 - $6,298	-100 Reduced 2.17%	4,502 $249,000
Q1 2018 May 14, 2018	BUY	$59.92 - $68.98 $10,486 - $12,071	175 Added 3.95%	4,602 $291,000
Q4 2017 Feb 09, 2018	BUY	$59.94 - $65.35 $11,988 - $13,069	200 Added 4.73%	4,427 $271,000
Q3 2017 Nov 02, 2017	BUY	$55.23 - $63.74 $233,457 - $269,428	4,227	4,227 $269,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of United Asset Strategies, Inc., based on Form 13F filings with the SEC.

Stay updated on United Asset Strategies, Inc. with notifications on news.